↓ Skip to main content

Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, November 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 232)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
12 news outlets
twitter
20 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare
Published in
Journal of Pharmaceutical Policy and Practice, November 2018
DOI 10.1186/s40545-018-0154-x
Pubmed ID
Authors

Jaden Brandt, Brenna Shearer, Steven G. Morgan

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 27%
Researcher 4 18%
Student > Bachelor 2 9%
Student > Ph. D. Student 1 5%
Professor > Associate Professor 1 5%
Other 0 0%
Unknown 8 36%
Readers by discipline Count As %
Social Sciences 4 18%
Medicine and Dentistry 3 14%
Economics, Econometrics and Finance 3 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Energy 1 5%
Other 2 9%
Unknown 7 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 110. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2020.
All research outputs
#186,678
of 15,694,927 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#2
of 232 outputs
Outputs of similar age
#7,615
of 388,361 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 31 outputs
Altmetric has tracked 15,694,927 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 232 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 388,361 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.